3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
34
Carcinoma, Non-Small-Cell Lung
26
Breast Neoplasms
25
Lung Neoplasms
24
Colonic Neoplasms
18
Head and Neck Neoplasms
16
Rectal Neoplasms
14
Sarcoma
10
Prostatic Neoplasms
10
Neoplasm Metastasis
9
Pancreatic Neoplasms
8
Neoplasms
7
Mouth Neoplasms
7
Melanoma
7
Esophageal Neoplasms
7
Ovarian Neoplasms
6
Glioblastoma
6
Adenomatous Polyposis Coli
6
Precancerous Conditions
5
Neuroblastoma
5
Liver Neoplasms
5
Central Nervous System Neoplasms
5
Carcinoma
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Recurrence
4
Oropharyngeal Neoplasms
4
Laryngeal Neoplasms
4
Hypopharyngeal Neoplasms
4
Interventions
Melphalan
3
Blood Specimen Collection
3
Magnetic Resonance Spectroscopy
2
thymoglobulin
1
sargramostim
1
romidepsin
1
montanide ISA 51
1
keyhole-limpet hemocyanin
1
ixazomib
1
detox adjuvant
1
Waiting Lists
1
Ursodeoxycholic Acid
1
Transplantation
1
Thalidomide
1
Tablets
1
Streptozocin
1
Radiosurgery
1
Radiation
1
Mercaptopurine
1
Leucovorin
1
Ketoconazole
1
Interleukin-2
1
Fulvestrant
1
Floxuridine
1
FANG vaccine
1
Docetaxel
1
Cord Blood Stem Cell Transplantation
1
Clinical Trials, Phase II as Topic
1
Circulating Tumor DNA
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Genetic Diseases, Inborn
×
Celecoxib
×
Clear all
NCT00808743
2013-05-16
PreDuoFAP
Radboud University Medical Center
Phase 2/3
Completed
37 enrolled